Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Endotypic trait responses to 12-month tirzepatide treatment for an obese patient with obstructive sleep apnea: a case report
Obesity facts, 2026;:1-11
Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study
Diabetes & vascular disease research, 2026;23(3):14791641261465360
Evaluation of the Clinical Effectiveness and Cost-Effectiveness of Tirzepatide for Type 2 Diabetes in Canada Using Bayesian Transportability Analysis
Value in health regional issues, 2026;:101666
Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study
Mayo Clinic proceedings, 2026
BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia
Current medical research and opinion, 2026;:1-10
Assessing the risk of diabetic retinopathy progression with GLP-1 receptor agonists: a systematic review and meta-analysis
BMC ophthalmology, 2026
Tirzepatide versus conventional GLP-1 receptor agonists for treatment simplification in type 2 diabetes mellitus: a real-world study
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review
Cureus, 2026;18(6):c457
Cost-Effectiveness of Semaglutide 2.4 mg for Obesity Disease Management in Japan: A Lifetime Economic Modeling Study Incorporating Retreatment Scenarios
Journal of health economics and outcomes research, 2026;13(1):288-296
Discovery of DDO-4279 as a PP5 degrader for the treatment of obesity
RSC medicinal chemistry, 2026
Case Report: Latent autoimmune diabetes in two young female patients successfully treated with oral semaglutide and basal insulin
Frontiers in endocrinology, 2026;17:1833794
Differential Anti-Inflammatory Effects of Semaglutide and Tirzepatide in Experimental Diabetes Mellitus
Current issues in molecular biology, 2026;48(7)
Post-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis
Cureus, 2026;18(6):e111786
GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms
Skin appendage disorders, 2026
[Effect of a combined physiotherapeutic approach on changes in functional parameters after endovitreal surgery of rhegmatogenous retinal detachment with a favorable anatomical outcome]
Vestnik oftalmologii;142(3):29-37
A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026;201:119717
Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial
Schizophrenia research, 2026;296:19-28
Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2026
Engineered circular RNA compatible with complete nucleoside modification and rolling circle translation through a Cap-independent translation enhancer
Nature biomedical engineering, 2026
Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction
Communications medicine, 2026